Neuren Pharmaceuticals | NEU - Srodki Pieniężne I Ekwiwalent





Srodki Pieniężne I Ekwiwalent Zmiana Data
Akebia Therapeutics USD 162.64M 22.2M 2026-03
Alaunos Therapeutics USD 354K 1.03M 2026-03
Avita Medical AUD 10.24M 1.98M 2025-12
Clinuvel Pharmaceuticals AUD 35.2M 3.62M 2024-06
Dianthus Therapeutics USD 627.67M 576.58M 2026-03
Genetic Signatures AUD 7.47M 33.32M 2025-06
Ionis Pharmaceuticals USD 1.92B 758M 2026-03
Medical Developments International AUD 17.84M 219K 2025-06
Neuren Pharmaceuticals AUD 5.91M 2.76M 2025-06
Organon & Co USD 1.12B 542M 2026-03
Paradigm Biopharmaceuticals AUD 16.82M 1M 2025-06
PYC Therapeutics AUD 153.05M 103.8M 2025-06
Starpharma Holdings AUD 15.41M 4.87M 2025-06
Tectonic Therapeutic USD 236.89M 16.9M 2026-03
Telix Pharmaceuticals AUD 207.16M 503.19M 2025-06
Viatris USD 1.8B 481.8M 2026-03
Xeris Pharmaceuticals USD 111.75M 708K 2026-03